Loading company…
Nicoya Lifesciences makes biosensor instruments for real-time, label-free analysis of biomolecular binding.
Founded in 2012 in Kitchener, Canada, Nicoya Lifesciences Inc. makes surface plasmon resonance biosensor instruments, including the OpenSPR and Alto systems. The instruments provide real-time, label-free binding data for over 600 research laboratories and academic institutions, particularly in drug discovery, antibody characterization and vaccine development. On December 16, 2021, the company raised USD 20.00 mn in Series A funding led by Whitecap Venture Partners, with Agilent Technologies and BDC Investments participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in